GlassScriptPhysician profile
Melvin D Law
NPI 1922099340
$6,171.58
in general payments reported to CMS, 2019-2025
19 companies · $1,536 in 2025
The $1,536 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.83 · 2023: $1,206 · 2024: $3,369 · 2025: $1,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,235 · Travel and Lodging: $1,875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,235.37 |
| Travel and Lodging | $1,875.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,982.91 | 2023-2024 | Everest Spinal System, Cayman Plate System, Navigation |
| Cerapedics INC. | $1,365.77 | 2023-2025 | I-Factor Peptide Enhanced Bone Graft |
| Amgen INC. | $677.88 | 2024-2025 | Evenity, Prolia, Prolia |
| Djo, LLC | $581.40 | 2024-2025 | Cmf |
| Medtronic, INC. | $312.23 | 2023-2025 | Mazor X System, Intellis Adaptivestim |
| Si-Bone, INC. | $172.13 | 2023 | |
| Ebi, LLC | $154.72 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Biocomposites INC | $141.52 | 2023 | Stimulan |
| Choice Spine, LLC | $131.27 | 2024-2025 | Thunderbolt Minimally Invasive Pedicle Screw Systems, Triton, Veo Lateral Interbody Fusion System |
| Radius Health, INC. | $128.57 | 2023-2025 | Tymlos |
| Augmedics INC. | $105.18 | 2025 | Xvision |
| Centinel Spine, LLC | $89.69 | 2023 | Prodisc C Vivo |
| Bioventus LLC | $80.77 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Alphatec Spine, INC | $69.33 | 2024-2025 | Invictus Open, Other - Miscellaneous |
| Tepha INC | $60.83 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $41.94 | 2025 | |
| Almatica Pharma LLC | $31.35 | 2024 | Teriparatide |
| Boston Scientific Corporation | $27.48 | 2024 | Intracept |
| Vertex Pharmaceuticals Incorporated | $16.61 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melvin Law listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.